Home/All Molecules/Roxithromycin

Roxithromycin Range

Comprehensive Roxithromycin portfolio for Franchise & Manufacturing.

Category
roxithromycin
Total Formulations
7
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Roxithromycin portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Roxithromycin batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Roxithromycin PCD Pharma Franchise Company

Roxithromycin PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Roxithromycin PCD pharma franchise company offering 7 WHO-GMP certified Roxithromycin formulations. We provide district-wise monopoly rights, quality-assured products and complete promotional support to pharma distributors, franchise partners and marketing professionals across India.

What is Roxithromycin?

Roxithromycin is a semi-synthetic macrolide antibiotic that stops bacterial growth by inhibiting protein synthesis at the 50S ribosomal subunit. It is a prescription-only antibiotic effective against many respiratory and skin pathogens. Reference data is available on PubChem.

Available Roxithromycin Formulations

Our Roxithromycin portfolio spans 7 formulations available in Tablet form. This range lets franchise partners serve multiple prescriber and patient segments from a single dependable supplier, with consistent quality across every batch.

Therapeutic Applications

Roxithromycin is used to treat respiratory tract infections, ENT infections such as pharyngitis and sinusitis, and skin and soft-tissue infections. It is prescribed by general physicians, ENT specialists and paediatricians.

Why Roxithromycin is a High-Potential Molecule for Distributors

As a well-tolerated once or twice-daily macrolide with good tissue penetration, Roxithromycin is a widely prescribed oral antibiotic with strong outpatient volumes. Distributors can rely on steady demand from general practice and ENT clinics across urban and semi-urban markets.

Why Choose Cafoli Lifecare

As a WHO-GMP certified and DCGI-approved pharma company, Cafoli Lifecare gives franchise partners district-wise monopoly rights, quality-assured products, attractive margins and complete promotional inputs including visual aids, product cards and marketing support. With a network of 1000+ partners across India, we combine dependable supply with genuine on-ground support to help you grow.

References

  1. PubChem - Roxithromycin
  2. PubMed - Roxithromycin clinical literature

Aceclofenac in Modern Clinical Practice

Our formulations of Roxithromycin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Roxithromycin in PCD Franchise

Start Your Roxithromycin Franchise with Cafoli Lifecare

Ready to launch your Roxithromycin PCD pharma franchise with monopoly rights and full promotional support? Call +91 95184 47302 or email info@cafoli.in to get started.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 7 WHO-GMP certified Roxithromycin tablet formulations for respiratory, ENT and skin infections.

Yes. We grant district-wise monopoly rights so each franchise partner markets Roxithromycin exclusively within their allotted territory.

Roxithromycin is prescribed by general physicians, ENT specialists and paediatricians for common bacterial infections.

Roxithromycin is usually taken before food and the full prescribed course should be completed to prevent bacterial resistance. It is a prescription-only antibiotic and should be used only as directed by a doctor.

A valid Drug License and GST registration are required to appoint a Roxithromycin PCD franchise with Cafoli Lifecare.